Innovative Research Award
Mohammad Alashqar
The Ohio State University, United States
| Mohammad Alashqar |
| Affiliation |
The Ohio State University |
| Country |
United States |
| Google Scholar ID |
2z79wywAAAAJ |
| Documents |
7 |
| Subject Area |
Digital Transformation |
| Event |
Business Global Awards |
| ORCID |
0009-0004-7635-8567 |
Mohammad Alashqar is affiliated with The Ohio State University and is associated with research spanning digital transformation and healthcare-related evidence synthesis. The publication record supplied for this profile includes systematic reviews, meta-analyses, pharmacotherapy research, health technology assessment, and cost-effectiveness analysis published in international scholarly journals. These works illustrate an interdisciplinary research orientation connecting digital health, clinical evidence, therapeutics, and health-economic evaluation. [1] [2] [3] [4]
Abstract
This academic recognition profile presents the research activities and publication record associated with Mohammad Alashqar, The Ohio State University, with a stated subject area of Digital Transformation. The supplied publications cover evidence-based evaluation of digital health interventions, systematic reviews and meta-analyses in heart failure, emerging therapies for hemophilia, and health-economic assessment of treatment strategies. One 2026 publication examines digital health interventions incorporating educational components for patients with heart failure, while other publications address pharmacological and economic dimensions of contemporary clinical care. [1] [2] [3] [4]
Keywords
Digital Transformation; Digital Health; Healthcare Research; Systematic Review; Meta-Analysis; Heart Failure; Hemophilia; Fitusiran; Pharmacotherapy; Health Economics; Cost-Effectiveness; Clinical Evidence; Evidence-Based Medicine.
Introduction
Digital transformation in healthcare encompasses the application of digital technologies, data-driven methods, and digitally enabled services to improve the delivery, evaluation, and management of healthcare. Academic research in this area increasingly intersects with clinical evidence synthesis, patient education, treatment evaluation, and health-economic analysis. Within this broader context, the supplied publication record associated with Mohammad Alashqar includes research addressing digital health interventions as well as systematic assessment of therapeutic approaches. [1]
The publications identified for this profile were published in 2026 in journals including Healthcare, Annals of Pharmacotherapy, Cardiology in Review, and Value in Health. Their subject matter ranges from patient-facing digital health interventions to pharmacological innovation and economic evaluation. Together, these studies demonstrate an emphasis on synthesizing available evidence to inform clinical and healthcare decision-making. [1] [2] [3] [4]
Research Profile
The supplied profile identifies Mohammad Alashqar with The Ohio State University in the United States and lists Digital Transformation as the principal subject area. The provided academic record contains seven documents. Citation and h-index values were not supplied in the source information and are therefore not assigned numerical values in this article.
Research Contributions
Digital health and patient education. The systematic review and meta-analysis titled Clinical Impact of Digital Health Interventions with Educational Components for Patients with Heart Failure examines digital health interventions that incorporate educational components for patients with heart failure. Published in Healthcare in August 2026, the study contributes to evidence concerning the clinical role of digitally enabled patient education and intervention strategies. [1]
Therapeutic innovation in hemophilia. The publication Fitusiran: A Novel Antithrombin-Targeting Therapy for Hemophilia A and B, With or Without Inhibitors addresses fitusiran as an antithrombin-targeting therapeutic approach for hemophilia A and B. Published in Annals of Pharmacotherapy in July 2026, the work contributes to the scholarly discussion surrounding emerging treatment strategies in hemophilia. [2]
Publications
- Clinical Impact of Digital Health Interventions with Educational Components for Patients with Heart Failure: A Systematic Review and Meta-Analysis. Healthcare. 2026;14(16):2460.[1]
- Fitusiran: A Novel Antithrombin-Targeting Therapy for Hemophilia A and B, With or Without Inhibitors. Annals of Pharmacotherapy. 2026. [2]
- Efficacy and Safety of Combination Pharmacotherapies With Standard Diuretic Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis. Cardiology in Review. 2026.[3]
- EE490 COST-EFFECTIVENESS OF FITUSIRAN PROPHYLAXIS VERSUS FACTOR VIII ON-DEMAND OR PROPHYLACTIC THERAPY FOR HEMOPHILIA A PATIENTS WITHOUT INHIBITORS. Value in Health. 2026.[4]
Research Impact
The supplied publications address questions with practical relevance to healthcare decision-making. The digital health study contributes evidence concerning interventions that combine technology with educational components for people living with heart failure. The fitusiran review considers an emerging therapeutic strategy in hemophilia, while the acute heart failure meta-analysis evaluates pharmacological combinations in a clinically significant setting. The health-economic study adds an economic perspective to prophylactic treatment selection. [1] [2] [3] [4]
Award Suitability
The supplied research record provides a reasonable academic basis for consideration under an Innovative Research Award category associated with Business Global Awards. Its relevance arises from the combination of digital health research, evidence synthesis, emerging therapeutics, clinical effectiveness assessment, and health-economic evaluation. The digital health publication is particularly aligned with the stated subject area of Digital Transformation because it evaluates digitally enabled interventions with an educational component for patients with heart failure. [1]
Conclusion
Mohammad Alashqar’s supplied publication record reflects multidisciplinary research at the intersection of digital transformation, healthcare evidence, pharmacotherapy, cardiovascular medicine, hematology, and health economics. The 2026 publications demonstrate engagement with systematic evidence synthesis and the evaluation of contemporary healthcare interventions. The combination of digital health research and clinically oriented evidence assessment provides a relevant foundation for academic recognition under an Innovative Research Award framework, subject to independent verification and the applicable award criteria. [1] [2] [3] [4]
External Links
References
- MDPI. (2026). Clinical Impact of Digital Health Interventions with Educational Components for Patients with Heart Failure: A Systematic Review and Meta-Analysis. Healthcare, 14(16), 2460.
https://doi.org/10.3390/healthcare14162460
- SAGE Publishing. (2026). Fitusiran: A Novel Antithrombin-Targeting Therapy for Hemophilia A and B, With or Without Inhibitors. Annals of Pharmacotherapy.
https://doi.org/10.1177/10600280251403512
- Wolters Kluwer. (2026). Efficacy and Safety of Combination Pharmacotherapies With Standard Diuretic Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis. Cardiology in Review.
https://doi.org/10.1097/crd.0000000000001337
- Elsevier. (2026). EE490 COST-EFFECTIVENESS OF FITUSIRAN PROPHYLAXIS VERSUS FACTOR VIII ON-DEMAND OR PROPHYLACTIC THERAPY FOR HEMOPHILIA A PATIENTS WITHOUT INHIBITORS. Value in Health.
https://doi.org/10.1016/j.jval.2026.03.783
- ORCID. (n.d.). Mohammad Alashqar — ORCID Profile.
https://orcid.org/0009-0004-7635-8567
- Research profile supplied for Mohammad Alashqar, The Ohio State University. Profile identifier: 2z79wywAAAAJ. Citation and h-index values were not supplied in the source data for this article.
https://scholar.google.com/citations?hl=en&user=2z79wywAAAAJ